Page 4 - Genmark Diagnostics News Today

Growing prevalence of superficial and systemic fungal infections have posed a significant challenge to healthcare providers across the world. Increasing prevalence of fungal infections of the skin, vagina and blood have prompted vendors to concentrate on developing swift and advanced molecular diagnostics in recent...

Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Global COVID-19 detection kits market value is projected to reach USD 6.1 billion by 2028, according to a new research report by Global Market...

TBRC's influenza diagnostic market report covers major trends and strategies that governments and market players are undertaking for business growth LONDON, March 16, 2022 /PRNewswire/

/PRNewswire/ -- Government policies provide a much-required impetus for the influenza diagnostics market to grow exponentially. The initiatives to counter...

/PRNewswire/ -- Government policies provide a much-required impetus for the influenza diagnostics market to grow exponentially. The initiatives to counter...

Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™

Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™

The firm obtained FDA breakthrough device designation for an NGS approach to identify up to 400 bacterial pathogens used to diagnose sepsis and other bacterial infections.

The firm saw growth in all of its diagnostics segments, including point-of-care testing and molecular laboratory testing.